BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 342092)

  • 1. Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium.
    Ueno Y; Kubota K; Ito T; Nakamura Y
    Cancer Res; 1978 Mar; 38(3):536-42. PubMed ID: 342092
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530.
    Garner RC; Miller EC; Miller JA
    Cancer Res; 1972 Oct; 32(10):2058-66. PubMed ID: 4404160
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivation and mutation induction in bacteria by microsomal metabolites.
    Garner RC
    Biochem Soc Trans; 1975; 3(1):65-9. PubMed ID: 1092573
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity and antibacterial activity of mycotoxins produced by Penicillium islandicum Sopp and Penicillium rugulosum.
    Stark AA; Townsend JM; Wogan GN; Demain AL; Manmade A; Ghosh AC
    J Environ Pathol Toxicol; 1978; 2(2):313-24. PubMed ID: 368283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative mutagenicity of aflatoxins using a Salmonella/trout hepatic enzyme activation system.
    Coulombe RA; Shelton DW; Sinnhuber RO; Nixon JE
    Carcinogenesis; 1982; 3(11):1261-4. PubMed ID: 6758974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action.
    Stark AA
    Annu Rev Microbiol; 1980; 34():235-62. PubMed ID: 7002024
    [No Abstract]   [Full Text] [Related]  

  • 9. 2,4,5- and 2,4,6-Trimethylaniline and their hydrochlorides.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():177-88. PubMed ID: 7049902
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagens, carcinogens, and computers.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1986; 209A():71-104. PubMed ID: 3529111
    [No Abstract]   [Full Text] [Related]  

  • 12. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
    Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro screening of carcinogens using DNA of the His- mutant of Salmonella typhimurium.
    Beljanski M; Le Goff L; Beljanski M
    Exp Cell Biol; 1982; 50(5):271-80. PubMed ID: 6754496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of mutagenic amino-gamma-carbolines in tryptophan pyrolysates.
    Kato R; Yamazoe Y; Ishii K; Mita S; Kamataki T; Sugimura T
    Adv Exp Med Biol; 1981; 136 Pt B():997-1009. PubMed ID: 7046392
    [No Abstract]   [Full Text] [Related]  

  • 16. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens.
    Moriya M; Ohta T; Sugiyama F; Miyazawa T; Shirasu Y
    J Natl Cancer Inst; 1979 Oct; 63(4):977-82. PubMed ID: 384011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of mutagenic activity of aflatoxins after UV-irradiation.
    Kleinwächter V; Koukalová B
    Acta Biol Med Ger; 1979; 38(9):1239-42. PubMed ID: 399142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
    Czygan P; Greim H; Garro A; Schaffner F; Popper H
    Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.